If Gaurav Gupta had to write his own epitaph, he says it would read: “I did it my way.” There’s a touch of Sinatra swagger to ...

Thinking about what to do with your Travere Therapeutics stock? You are not alone. The past few months have been busy for this biotech name, giving investors new reasons to pay attention. Maybe you ...